Karson S. Putt
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Paul J. Hergenrother (11 shared papers)Philip Stewart Low (20 shared papers)Scott Poh (3 shared papers)Robin S. Dothager (3 shared papers)Jyoti Roy (4 shared papers)Hua Jin (1 shared paper)Myung‐Haing Cho (1 shared paper)Martin S. Hoagland (1 shared paper)
- Journals
- Oncotarget (3 papers)ChemBioChem (2 papers)Journal of the American Chemical Society (2 papers)PLoS ONE (2 papers)Analytical Biochemistry (2 papers)
- Partner nations
- United StatesIndiaPuerto Rico
In The Last Decade
Karson S. Putt
42 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 91
- Biomaterials 154
- Oncology 230
- Molecular Biology 474
- Organic Chemistry 233
- Drug Discovery 2
Countries citing papers authored by Karson S. Putt
This map shows the geographic impact of Karson S. Putt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karson S. Putt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karson S. Putt more than expected).
Fields of papers citing papers by Karson S. Putt
This network shows the impact of papers produced by Karson S. Putt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karson S. Putt. The network helps show where Karson S. Putt may publish in the future.
Co-authors
The 25 scholars most cited alongside Karson S. Putt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 300 | |
| 2 | 2004 | 109 | |
| 3 | 2019 | 92 | |
| 4 | 2005 | 91 | |
| 5 | 2015 | 90 | |
| 6 | 2015 | 73 | |
| 7 | 2017 | 72 | |
| 8 | 2003 | 68 | |
| 9 | 2008 | 57 | |
| 10 | 2018 | 52 | |
| 11 | 2017 | 51 | |
| 12 | 2019 | 41 | |
| 13 | 2016 | 38 | |
| 14 | 2016 | 37 | |
| 15 | 2017 | 35 | |
| 16 | 2021 | 31 | |
| 17 | 2004 | 29 | |
| 18 | 2022 | 29 | |
| 19 | 2004 | 28 | |
| 20 | 2015 | 27 |
About Karson S. Putt
Karson S. Putt is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Rheumatology and Oncology, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Cell death mechanisms and regulation (5 papers), Synthesis and biological activity (4 papers), Alzheimer's disease research and treatments (3 papers), Enzyme function and inhibition (3 papers), Molecular Sensors and Ion Detection (3 papers) and Folate and B Vitamins Research (3 papers). The work is most often cited by research in Biomaterials (154 citations), Oncology (230 citations), Molecular Biology (474 citations), Organic Chemistry (233 citations) and Drug Discovery (2 citations). Karson S. Putt has collaborated with scholars based in United States, India and Puerto Rico. Frequent co-authors include Paul J. Hergenrother, Philip Stewart Low, Scott Poh, Robin S. Dothager, Jyoti Roy, Hua Jin, Myung‐Haing Cho, Martin S. Hoagland, Mona I. Churchwell and Jung‐Taek Kwon. Their work appears in journals such as Oncotarget, ChemBioChem, Journal of the American Chemical Society, PLoS ONE and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.